Pharmaceutical Litigation Attorneys
Pharmaceutical Litigation
Helping the Injured Seek Justice and Financial Compensation.

Stryker Hip Implants

Individuals who received a Stryker Accolade hip replacement may be at risk of fretting and corrosion, which can cause the failure of the metal implant. Complaints have been filed in New Jersey state court and they allege that the Stryker Accolade TMZF hip stem and LFIT anatomic V40 femoral head are defectively designed and manufactured. The Stryker Accolade implant lawsuit alleges that the device sheds metal particles such as chromium and cobalt into patient's bodies, resulting in metal blood poisoning (metallosis) which causes tumors and damage to tissue and bone.

The Stryker Accolade hip lawsuits are filed in the same court where numerous lawsuits are pending over problems with the Stryker Rejuvenate and ABG II hip replacements. These were recalled in July 2012 over reports that they may corrode, fret and fail within a few years after surgery. Unlike traditional implants that feature a single femoral component, the Stryker Rejuvenate hip implant consists of two pieces that fit inside each other to allow the surgeon to customize the length of the femoral component based on the individual. This design has been linked to an increased risk of problems that may result from the release of microscopic metal debris as the chromium-cobalt neck rubs against the titanium femoral stem.

Hip implants are typically expected to last 15-20 years but the Stryker Rejuvenate recall was issued less than two years after the design was introduced.

The pharmaceutical litigation attorneys of Napoli Shkolnik PLLC are currently handling claims involving Stryker V40 femoral heads. If you are unsure whether or not you or a loved one received a V40 femoral head, we can contact the hospital on your behalf to obtain this information. Call Napoli Shkolnik PLLC for a free consultation today.